Join
10x Genomics Inc. logo

TXG

NASDAQ

10x Genomics Inc.

SectorIndustrialsIndustryBiotechnology: Laboratory Analytical InstrumentsIPO2019
$29.14-1.91 (-6.17%)
News25/Ratings12

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell ATAC for measuring epigenetics comprising the physical organization of DNA; and single cell multiome ATAC + gene expression for measuring the genetic activity and epigenetic programming in the same cells across tens of thousands of cells in a single experiment. The company also provides visium spatial gene expression solution for measuring spatial gene expression patterns across a single tissue sample or gene expression and protein co-detection when combined with immunofluorescence. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.

News · 26 weeks48+43%
2025-12-14: 02025-12-21: 02025-12-28: 12026-01-04: 32026-01-11: 52026-01-18: 12026-01-25: 02026-02-01: 02026-02-08: 32026-02-15: 12026-02-22: 42026-03-01: 52026-03-08: 02026-03-15: 12026-03-22: 42026-03-29: 12026-04-05: 02026-04-12: 22026-04-19: 32026-04-26: 22026-05-03: 22026-05-10: 02026-05-17: 02026-05-24: 32026-05-31: 02026-06-07: 7
2025-12-142026-06-07
Mix2590d
  • Insider11(44%)
  • Other7(28%)
  • SEC Filings4(16%)
  • Earnings2(8%)
  • Analyst1(4%)

Latest news

25 items

TXG FAQ

7 questions
  • What does 10x Genomics Inc. do?
    10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their...
  • Where does TXG stock trade?
    10x Genomics Inc. (TXG) is listed on NASDAQ.
  • What sector and industry is TXG in?
    10x Genomics Inc. operates in the Industrials sector, Biotechnology: Laboratory Analytical Instruments industry.
  • When did 10x Genomics Inc. go public?
    10x Genomics Inc. (TXG) completed its IPO in 2019.
  • What are analysts saying about TXG?
    10x Genomics Inc. has had 8 recent analyst actions on file. The most recent action was from William Blair: Outperform on 2026-03-31. Recent price targets range from $1200.00 to $3500.00.
  • What companies are similar to TXG?
    Notable peers in the same industry include A (Agilent Technologies Inc.), WAT (Waters Corporation), MTD (Mettler-Toledo International Inc.), PKI (PerkinElmer Inc.), RVTY (Revvity Inc.). Compare TXG side-by-side with any of them on Quantisnow.
  • How can I track TXG on Quantisnow?
    Quantisnow aggregates 10x Genomics Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow TXG to receive live email and push alerts on every new disclosure.